Abivax S.a.
Clinical trials sponsored by Abivax S.a., explained in plain language.
-
New hope for Crohn's sufferers: experimental drug enters key trial
Disease control Recruiting nowThis study tests an experimental drug called obefazimod in 212 adults with moderate-to-severe Crohn's disease who haven't responded well to other treatments. The trial compares obefazimod to a placebo over 12 weeks (induction), then 40 weeks (maintenance), and finally a 48-week e…
Phase: PHASE2 • Sponsor: Abivax S.A. • Aim: Disease control
Last updated May 26, 2026 02:22 UTC
-
Healthy volunteers help test Easier-to-Swallow drug form
Knowledge-focused Recruiting nowThis study is testing a new minitablet version of the drug obefazimod in 44 healthy adults aged 18 to 55. The goal is to see how the body processes the minitablet compared to the current capsule and whether the minitablet tastes acceptable. This is an early-stage study that does …
Phase: PHASE1 • Sponsor: Abivax S.A. • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC